Dr. Catherine Maari, MD
Claim this profileInnovaderm Research Inc.
Studies Atopic Dermatitis
Studies Eczema
3 reported clinical trials
4 drugs studied
Affiliated Hospitals
More about Catherine Maari, MD
Clinical Trial Related2 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments Catherine Maari, MD has experience with
- EP262
- Daxdilimab
- Vehicle Control Gel
- Lotilaner Gel, 2.0%
Breakdown of trials Catherine Maari, MD has run
Atopic Dermatitis
Eczema
Alopecia
Alopecia Areata
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Catherine Maari, MD specialize in?
Catherine Maari, MD focuses on Atopic Dermatitis and Eczema. In particular, much of their work with Atopic Dermatitis has involved treating patients, or patients who are undergoing treatment.
Is Catherine Maari, MD currently recruiting for clinical trials?
No, Catherine Maari, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Catherine Maari, MD has studied deeply?
Yes, Catherine Maari, MD has studied treatments such as EP262, Daxdilimab, Vehicle control gel.
What is the best way to schedule an appointment with Catherine Maari, MD?
Apply for one of the trials that Catherine Maari, MD is conducting.
What is the office address of Catherine Maari, MD?
The office of Catherine Maari, MD is located at: Innovaderm Research Inc., Montréal, Quebec H2X 2V1 Canada. This is the address for their practice at the Innovaderm Research Inc..
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.